| Literature DB >> 19196740 |
Jun Zhao1, Tao Liu, Long Ma, Ming Yan, Zhengyi Gu, Yi Huang, Fang Xu, Yu Zhao.
Abstract
Nymphaea candida is traditional Uighur medicine that is commonly used to treat head pains, cough, hepatitis and hypertension in Xinjiang of China. In this article, the extract of N. candida was measured for antioxidant activity, using 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals scavenging assay and reducing power determination, and compared with those of the positive controls of butylated hydroxytoluene (BHT) and gallic acid (GA). The active extract was further purified by liquid-liquid partition to afford four fractions, of which the ethyl acetate-soluble (EA) fraction (NCE) exhibited the strongest antioxidant capacity with IC(50) value of 12.6 μg/mL for DPPH. Thirteen phenolic compounds were isolated from this fraction, and they all showed significant antioxidant activities in DPPH model system. Furthermore, NCE showed potent antioxidant capacity with IC(50) value of 59.32 μg/mL, 24.48 μg/mL and 86.85 μg/mL, for O(2) (-), ·OH and H(2)O(2) radicals, respectively. Moreover, NCE on BCG plus LPS-induced immunological liver injury was evaluated using primary cultured rat hepatocytes. NCE produced significant hepatoprotective effects as evidenced by decreased supernatant enzyme activities (AST-aspartate transaminase, P < .01; ALT-alanine transferase, P < .01) and nitric oxide (NO, P < .01) production. These results revealed the in vitro antioxidant and hepatoprotective activities of NCE against immunological liver injury. Further investigations are necessary to verify these activities in vivo.Entities:
Year: 2011 PMID: 19196740 PMCID: PMC3136535 DOI: 10.1093/ecam/nep003
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Reducing power of the extracts from N. candida, GA and BHT at different concentrations. Each value represents mean ± SD (n = 6).
Figure 2DPPH radicals scavenging activities of the extracts from N. candida, GA and BHT at different concentrations. Each value represents mean ± SD (n = 6).
Total phenolic content of N. candida extracts.
| Ethanol extracts (NCA) | Ethyl acetate Fr. (NCE) |
| Aqueous residue Fr. (NCW) | |
|---|---|---|---|---|
| Total phenolic content (g/100 g) | 7.52 ± 1.8 | 25.7 ± 2.1 | 12.11 ± 1.29 | 0.38 ± 1 |
DPPH radical scavenging activities of 13 phenolic compounds from NCE.
| Compounds | IC50 ( |
|---|---|
| Gallic acid ( | 1.78 |
| Gallic acid methyl ester ( | 2.21 |
|
| 2.53 |
| Quercetin ( | 1.97 |
| Kaempferol ( | 5.56 |
| Quercetin 3-methyl ether ( | 4.78 |
| Tricin 7-methyl ether ( | 6.26 |
| Astragalin ( | 63.53 |
| Quercetin 3-methyl ether 3′ | 28.20 |
| Quercetin 3′- | 20.11 |
| Isoquercitrin ( | 9.42 |
| Rutin ( | 16.62 |
| Kaempferol - 3- | 81.22 |
Scavenging of, superoxide (O2 −), hydroxyl radical (·OH) and hydrogen peroxide (H2O2) by NCE.
| Group | Concentration | O2 − |
| H2O2 | |||
|---|---|---|---|---|---|---|---|
| ( | Inhibition (%) | IC50 ( | Inhibition (%) | IC50 ( | Inhibition (%) | IC50 ( | |
| Gallic acid | 2 | 9.05 ± 0.10 | 30.56 ± 1.63 | 11.12 ± 1.12 | |||
| 10 | 16.95 ± 0.34 | 29.39 | 43.2 ± 0.53 | 16.29 | 20.8 ± 1.54 | 31.87 | |
| 50 | 68.72 ± 0.25 | 62.14 ± 0.74 | 63.7 ± 1.28 | ||||
|
| |||||||
| BHT | 2 | 5.57 ± 0.47 | 20.85 ± 1.02 | 4.42 ± 0.12 | |||
| 10 | 23.12 ± 1.32 | 71.87 | 31.2 ± 0.44 | 83.56 | 18.29 ± 0.29 | 131.6 | |
| 50 | 39.83 ± 1.21 | 45.69 ± 1.89 | 30.43 ± 0.31 | ||||
|
| |||||||
| NCE | 10 | 11.6 ± 0.70 | 25.43 ± 0.22 | 19.02 ± 0.64 | |||
| 20 | 25.01 ± 1.01 | 59.32 | 38.22 ± 0.96 | 24.28 | 27.22 ± 1.49 | 86.45 | |
| 50 | 44.16 ± 0.43 | 59.02 ± 1.16 | 40.91 ± 1.26 | ||||
IC50, value of the 50% inhibition concentration; inhibition (%), percent inhibition of means of six replicates from the control.
Cytotoxicity of NCE and Grz against primarily cultured rat hepatocytes.
| Group | Concentration ( | Inhibition (%) | TC50 ( |
|---|---|---|---|
| Grz | 200 | 29.12 ± 0.02 | 465.12 |
| 100 | 16.19 ± 0.06 | ||
| 25 | 4.21 ± 0.08 | ||
| 5 | 0.86 ± 0.06 | ||
|
| |||
| NCE | 200 | 40.12 ± 0.07 | 393.65 |
| 100 | 19.83 ± 0.06 | ||
| 25 | 3.26 ± 0.21 | ||
| 5 | 1.60 ± 0.1 | ||
TC50, value of the 50% inhibition concentration (%); inhibition (%), percent inhibition of means of six replicates from the control.
Effect of NCE on supernatant AST levels in immunologic injury in primary cultured rat hepatocytes in vitro.
| Group | Dose | AST (U/L) | |||
|---|---|---|---|---|---|
|
| 3 hours | 6 hours | 12 hours | 24 hours | |
| Control | — | 21.45 ± 2.92 | 24.17 ± 3.21 | 40.87 ± 6.01 | 41.00 ± 8.07 |
| BCG + LPS | — | 57.03 ± 2.88a | 90.55 ± 10.46a | 101.88 ± 10.71a | 63.34 ± 8.90a |
| BCG + LPS + Grz | 5 | 65.15 ± 16.64 | 59.89 ± 8.66b | 73.84 ± 10.89b | 37.67 ± 6.16b |
| 10 | 48.53 ± 10.34 | 43.55 ± 12.02b | 60.66 ± 6.05b | 41.12 ± 16.37b | |
| 20 | 57.34 ± 9.57 | 59.68 ± 16.59b | 55.06 ± 8.17b,c | 33.38 ± 7.92b | |
| BCG + LPS + NCE | 5 | 67.78 ± 6.41 | 53.79 ± 8.83b | 58.66 ± 4.72b | 37.76 ± 3.01b |
| 20 | 56.88 ± 13.46 | 55.55 ± 7.20b,d | 48.72 ± 2.10b | 35.43 ± 4.34b | |
| 80 | 57.65 ± 6.24 | 36.71 ± 10.00b,d | 49.94 ± 6.25b | 35.63 ± 10.00b | |
Values are the mean ± SD, n = 6. a P < .01 compared with control group; b P < .01 compared with BCG + LPS group; c P < .05 compared with BCG + LPS + Grz group (5 μg/mL); d P < .05 compared with BCG + LPS + NCE group (5 μg/mL).
Effect of NCE on supernatant ALT levels in immunologic injury in primary cultured rat hepatocytes in vitro.
| Group | Dose | ALT (U/L) | |||
|---|---|---|---|---|---|
|
| 3 hours | 6 hours | 12 hours | 24 hours | |
| Control | — | 3.16 ± 0.58 | 3.68 ± 0.42 | 4.68 ± 0.31 | 3.65 ± 0.53 |
| BCG + LPS | — | 5.69 ± 0.91a | 7.68 ± 0.74a | 9.43 ± 1.23a | 6.58 ± 0.83a |
| BCG + LPS + Grz | 5 | 5.12 ± 1.36 | 4.08 ± 1.00b | 6.61 ± 1.01b | 3.11 ± 0.59b |
| 10 | 3.62 ± 0.73b,e | 3.29 ± 1.05b | 5.14 ± 0.85b,e | 3.80 ± 1.42b | |
| 20 | 3.98 ± 0.64b | 4.80 ± 1.65b | 4.87 ± 0.80b,d | 3.20 ± 1.24b | |
| BCG + LPS + NCE | 5 | 5.71 ± 1.10 | 3.95 ± 0.53b | 6.06 ± 0.70b | 3.52 ± 0.37b |
| 20 | 4.25 ± 1.17c | 3.77 ± 0.63b | 4.88 ± 0.30b | 3.21 ± 0.49b | |
| 80 | 4.71 ± 1.23 | 2.53 ± 0.97b | 4.07 ± 0.86b | 3.29 ± 0.98b | |
Values are the mean ± SD, n = 6. a P < .01 compared with control group; b P < .01 and c P < .05 compared with BCG + LPS group; d P < .01 and e P < .01 compared with BCG + LPS + Grz group (5 μg/mL).
Effect of NCE on supernatant NO production in immunologic injury in primary cultured rat hepatocytes in vitro.
| Group | Dose | NO ( | |||
|---|---|---|---|---|---|
|
| 3 hours | 6 hours | 12 hours | 24 hours | |
| Control | — | 2.38 ± 0.19 | 2.52 ± 0.18 | 2.80 ± 0.21 | 2.82 ± 0.21 |
| BCG + LPS | — | 5.03 ± 0.33a | 8.51 ± 0.49a | 10.57 ± 0.77a | 7.41 ± 0.77a |
| BCG + LPS + Grz | 5 | 4.96 ± 0.31 | 6.49 ± 0.74b | 8.13 ± 0.55b | 5.73 ± 0.64b |
| 10 | 4.25 ± 0.43b,c | 5.83 ± 0.48b,c | 7.65 ± 0.55b,c | 4.84 ± 0.4b,d | |
| 20 | 3.63 ± 0.38b,c | 4.83 ± 0.55b,c | 6.08 ± 0.39b,c | 4.64 ± 0.51b,c | |
| BCG + LPS + NCE | 5 | 5.10 ± 0.13 | 6.41 ± 0.73b | 7.89 ± 0.39b | 5.87 ± 0.45b |
| 20 | 4.53 ± 0.73 | 5.84 ± 0.51b | 7.41 ± 0.71b | 5.50 ± 0.58b | |
| 80 | 4.44 ± 0.7 | 5.07 ± 0.60b,e | 6.69 ± 0.39b,e | 5.08 ± 0.69b,f | |
Values are the mean ± SD, n = 6. a P < .01 compared with control group; b P < .01 compared with BCG + LPS group; c P < .05; d P < .01 compared with BCG + LPS + Grz group (5 μg/mL); e P < .05 and f P < .01 compared with BCG + LPS + NCE group (5 μg/mL).